CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F06%3A00009709" target="_blank" >RIV/00216208:11110/06:00009709 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/06:00001366
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
Original language description
diffuse large-B-cell lymphoma, CHOP, chemotherapy, rituximab
Czech name
Srovnání CHOP a podobná chemoterapie s rituximabem proti samotné chemoterapii u mladých nemocných s difúzním velkobuněčným lymfomem B řady: randomizovaná kontrolovaná studie MabThera International Trial (MInT) skupiny
Czech description
difúzní velkobuněčný lymfom, CHOP, chemoterapie, rituximab
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2006
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Lancet Oncology
ISSN
1470-2045
e-ISSN
—
Volume of the periodical
7
Issue of the periodical within the volume
5
Country of publishing house
US - UNITED STATES
Number of pages
13
Pages from-to
379-391
UT code for WoS article
—
EID of the result in the Scopus database
—